In this section
@article{Fletcher:2016:10.1089/aid.2015.0315,
author = {Fletcher, P and Herrera, C and Armanasco, N and Nuttall, J and Shattock, RJ},
doi = {10.1089/aid.2015.0315},
journal = {AIDS Research and Human Retroviruses},
pages = {334--338},
title = {Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues},
url = {http://dx.doi.org/10.1089/aid.2015.0315},
volume = {32},
year = {2016}
}
TY - JOUR
AB - The potential of maraviroc (MVC), a small-molecule CCR5 antagonist, as a candidate to prevent HIV-1 sexual transmission by oral or topical dosing has not yet been completely established. Using relevant cellular and mucosal tissue explant models, we show partial antiviral activity of MVC when tested in multiple preclinical dosing strategies.
AU - Fletcher,P
AU - Herrera,C
AU - Armanasco,N
AU - Nuttall,J
AU - Shattock,RJ
DO - 10.1089/aid.2015.0315
EP - 338
PY - 2016///
SN - 0889-2229
SP - 334
TI - Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues
T2 - AIDS Research and Human Retroviruses
UR - http://dx.doi.org/10.1089/aid.2015.0315
VL - 32
ER -